Antimicrobial Resistance (AMR) poses a severe threat to global health, resulting in over 700,000 annual deaths and constituting a significant worldwide health crisis. The escalating ineffectiveness of most current drugs in combating multidrug-resistant (MDR) strains of bacteria and fungi underscores the urgent necessity for potent novel antimicrobials. To address this pressing issue, Peptomer Therapeutics has pioneered innovative platforms designed for the development of a diverse array of antimicrobial peptides and oligomers. We are based at the BSC BioNEST Bio-Incubator, Regional Centre for Biotechnology (RCB), Faridabad, India.
Dr Kantaraja Chindera
Director
PhD, Molecular Biology
15 years of experience in drug delivery and antimicrobials, specializing in molecular microbiology. His doctoral research resulted in the establishment of a spinout company, currently valued at over £10 million.
Dr Manohar Mahato
Director
PhD, Chemistry
15 years of experience in small molecule and peptide synthesis.
Dr Ravindra P Veeranna
Co-founder
PhD, Biotechnology
20 years of research expertise in the fields of cell and molecular biology.
Ms Princy
Senior Scientist
MSc, (PhD), Chemistry
3 years of professional expertise in specialized small molecule and peptide synthesis.
Ms Anjali Pandey
Scientist
MSc Biotechnology
1 year of experience in the field of cell and molecular biology.
Ms Anshul Teji
Scientist
MSc Biotechnology
1 year of experience in the field of cell and molecular biology.
Mr Sanoj Kumar
Lab Technican